Quadrant Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $723K | Sell |
11,131
-50
| -0.4% | -$3.25K | 0.33% | 72 |
|
|
2019
Q3 | $709K | Sell |
11,181
-1,280
| -10% | -$81.2K | 0.35% | 71 |
|
|
2019
Q2 | $842K | Sell |
12,461
-5,970
| -32% | -$403K | 0.44% | 70 |
|
|
2019
Q1 | $1.2M | Sell |
18,431
-310
| -2% | -$20.2K | 0.66% | 57 |
|
|
2018
Q4 | $1.17M | Sell |
18,741
-1,450
| -7% | -$90.7K | 0.77% | 55 |
|
|
2018
Q3 | $1.56M | Buy |
20,191
+400
| +2% | +$30.9K | 0.99% | 45 |
|
|
2018
Q2 | $1.4M | Sell |
19,791
-125
| -0.6% | -$8.86K | 1% | 47 |
|
|
2018
Q1 | $1.5M | Sell |
19,916
-117
| -0.6% | -$8.82K | 1.1% | 41 |
|
|
2017
Q4 | $1.44M | Sell |
20,033
-2,513
| -11% | -$180K | 1.01% | 46 |
|
|
2017
Q3 | $1.83M | Buy |
22,546
+248
| +1% | +$20.1K | 1.35% | 35 |
|
|
2017
Q2 | $1.58M | Sell |
22,298
-787
| -3% | -$55.7K | 1.23% | 39 |
|
|
2017
Q1 | $1.57M | Hold |
23,085
| – | – | 1.27% | 36 |
|
|
2016
Q4 | $1.65M | Sell |
23,085
-8,854
| -28% | -$634K | 1.42% | 36 |
|
|
2016
Q3 | $2.53M | Buy |
31,939
+190
| +0.6% | +$15K | 2.14% | 17 |
|
|
2016
Q2 | $2.65M | Buy |
31,749
+1,924
| +6% | +$161K | 2.23% | 14 |
|
|
2016
Q1 | $2.74M | Buy |
29,825
+1,379
| +5% | +$127K | 2.33% | 11 |
|
|
2015
Q4 | $2.88M | Buy |
28,446
+358
| +1% | +$36.2K | 2.33% | 7 |
|
|
2015
Q3 | $2.76M | Buy |
28,088
+2,042
| +8% | +$201K | 2.34% | 7 |
|
|
2015
Q2 | $3.05M | Buy |
26,046
+3,520
| +16% | +$412K | 2.61% | 6 |
|
|
2015
Q1 | $2.21M | Buy |
22,526
+1,703
| +8% | +$167K | 1.9% | 20 |
|
|
2014
Q4 | $1.96M | Sell |
20,823
-425
| -2% | -$40.1K | 1.69% | 27 |
|
|
2014
Q3 | $2.26M | Sell |
21,248
-150
| -0.7% | -$16K | 2.16% | 13 |
|
|
2014
Q2 | $1.77M | Buy |
+21,398
| New | +$1.77M | 1.7% | 27 |
|